Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Hikma Buys Teligent Assets To Expand Into Canada
Deal Worth $46m For Canadian Sterile Injectable Assets Follows Teligent Bankruptcy
Jan 17 2022
•
By
David Wallace
The deal represents Hikma’s first foray into Canada • Source: Donisl / Alamy Stock Photo
More from Deals
More from Business